Your browser doesn't support javascript.
loading
Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts.
Zeidan, Amer M; Platzbecker, Uwe; Garcia-Manero, Guillermo; Sekeres, Mikkael A; Fenaux, Pierre; DeZern, Amy E; Greenberg, Peter L; Savona, Michael R; Jurcic, Joseph G; Verma, Amit K; Mufti, Ghulam J; Buckstein, Rena; Santini, Valeria; Shetty, Jeevan K; Ito, Rodrigo; Zhang, Jennie; Zhang, George; Ha, Xianwei; Backstrom, Jay T; Komrokji, Rami S.
Afiliação
  • Zeidan AM; Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT.
  • Platzbecker U; Department of Hematology, Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sekeres MA; Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
  • Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Université de Paris 7, Paris, France.
  • DeZern AE; The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, MD.
  • Greenberg PL; Stanford Cancer Center, Stanford Hospital, Stanford, CA.
  • Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN.
  • Jurcic JG; Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY.
  • Verma AK; Department of Oncology, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY.
  • Mufti GJ; Department of Haemato-Oncology, King's College Hospital, London, United Kingdom.
  • Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Santini V; MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy.
  • Shetty JK; Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland.
  • Ito R; Bristol Myers Squibb, Princeton, NJ.
  • Zhang J; Bristol Myers Squibb, Princeton, NJ.
  • Zhang G; Bristol Myers Squibb, Princeton, NJ.
  • Ha X; Bristol Myers Squibb, Princeton, NJ.
  • Backstrom JT; Acceleron Pharma, Cambridge, MA.
  • Komrokji RS; Moffitt Cancer Center, Tampa, FL.
Blood ; 140(20): 2170-2174, 2022 11 17.
Article em En | MEDLINE | ID: mdl-35797468
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Receptores de Activinas Tipo II Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Receptores de Activinas Tipo II Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2022 Tipo de documento: Article